Cargando…

1336. Impact of Procalcitonin-Guided Antibiotic Management in Chronic Obstructive Pulmonary Disease Exacerbation and Community-Acquired Pneumonia

BACKGROUND: Chronic obstructive pulmonary disease (COPD) exacerbation and community-acquired pneumonia (CAP) are major drivers of antibiotic overuse, primarily due to challenges in pathogen identification. Procalcitonin is a serum biomarker that assists in distinguishing bacterial infection from oth...

Descripción completa

Detalles Bibliográficos
Autores principales:	Triner, Molly, Patel, Sunita, Craft, Rachael, Rajkumar, Aarthi, Patel, Tejas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Oxford University Press 2019
Materias:	Abstracts
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6809209/ http://dx.doi.org/10.1093/ofid/ofz360.1200

Ejemplares similares

1479. Evaluating the Impact of Procalcitonin on Antibiotic Utilization in Chronic Obstructive Pulmonary Disease Exacerbations
por: Lin, Kevin, et al.
Publicado: (2018)

Procalcitonin and CRP as Biomarkers in Discrimination of Community-acquired Pneumonia and Exacerbation of COPD
por: Çolak, Ayfer, et al.
Publicado: (2017)

Procalcitonin-guided antibiotic therapy in acute exacerbation of chronic obstructive pulmonary disease: An updated meta-analysis
por: Li, Zhuying, et al.
Publicado: (2019)

Procalcitonin-Guided Antibiotic Use in Acute Exacerbations of Idiopathic Pulmonary Fibrosis
por: Ding, Juanjuan, et al.
Publicado: (2013)

Procalcitonin to guide antibiotic administration in COPD exacerbations: a meta-analysis
por: Mathioudakis, Alexander G., et al.
Publicado: (2017)

Introduction of Procalcitonin Testing and Antibiotic Utilization for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Ulrich, Robert J, et al.
Publicado: (2019)

Procalcitonin guided antibiotic therapy of acute exacerbations of asthma: a randomized controlled trial
por: Tang, Jianguo, et al.
Publicado: (2013)

Procalcitonin and C-Reactive Protein in Hospitalized Adult Patients With Community-Acquired Pneumonia or Exacerbation of Asthma or COPD
por: Bafadhel, Mona, et al.
Publicado: (2011)

Antibiotic Treatment of Severe Exacerbations of Chronic Obstructive Pulmonary Disease with Procalcitonin: A Randomized Noninferiority Trial
por: Verduri, Alessia, et al.
Publicado: (2015)

Procalcitonin guidance significantly reduces antibiotic duration in community-acquired pneumonia: the 'ProCAP' study
por: Christ-Crain, M, et al.
Publicado: (2005)

The potential of molecular diagnostics and serum procalcitonin levels to change the antibiotic management of community-acquired pneumonia
por: Gilbert, David, et al.
Publicado: (2016)

Procalcitonin Is Useful for Evaluating Patients with Ambiguous Presentation and for Early Discontinuation of Antibiotics in Community-acquired Pneumonia
por: Schuetz, Philipp
Publicado: (2020)

The role of lung ultrasound in procalcitonin-guided antibiotic discontinuation in ventilator-associated pneumonia
por: Ammar, Mona A., et al.
Publicado: (2022)

Procalcitonin-guided antibiotics in severe sepsis
por: Simon, Peter, et al.
Publicado: (2008)

Using Procalcitonin to Guide Antibiotic Therapy
por: Rhee, Chanu
Publicado: (2016)

Role of procalcitonin in diagnosis of community acquired pneumonia in Children
por: Ratageri, Vinod H., et al.
Publicado: (2022)

173 Introduction of Procalcitonin Testing Did Not Reduce Antibiotic Utilization for Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Rao, Krishna, et al.
Publicado: (2014)

Procalcitonin for Antibiotic Prescription in Chronic Obstructive Pulmonary Disease Exacerbations: Systematic Review, Meta-Analysis, and Clinical Perspective
por: Chen, Ken, et al.
Publicado: (2020)

Procalcitonin-guided antibiotic discontinuation in ventilator-associated pneumonia: a prospective observational study
por: Wang, Qiushi, et al.
Publicado: (2019)

Clinical Significance of Procalcitonin, C-Reactive Protein, and Interleukin-6 in Helping Guide the Antibiotic Use for Patients with Acute Exacerbations of Chronic Obstructive Pulmonary Disease
por: Song, Wen, et al.
Publicado: (2021)

Spinal epidural abscess caused by a community acquired extended spectrum beta lactamase producing Klebsiella pneumonia
por: Dang, Vinh, et al.
Publicado: (2018)

The effect of vitamin C on procalcitonin biomarker in community‐acquired pneumonia
por: Nikzad, Mahsa, et al.
Publicado: (2021)

ROLE OF PROCALCITONIN IN PATIENTS WITH COVID-19 AND HOSPITAL-ACQUIRED PNEUMONIA
por: KUMAR, MYTHRI ANIL, et al.
Publicado: (2022)

Procalcitonin-guided diagnosis and antibiotic stewardship revisited
por: Sager, Ramon, et al.
Publicado: (2017)

Sex Differences in the Treatment of Uveal Melanoma in a Group of 1336 Patients
por: Romanowska-Dixon, Bożena, et al.
Publicado: (2023)

Procalcitonin kinetics to guide sequential invasive-noninvasive mechanical ventilation weaning in patients with acute exacerbation of chronic obstructive pulmonary disease and respiratory failure: procalcitonin’s adjunct role
por: Lin, Shao-Hua, et al.
Publicado: (2021)

Procalcitonin algorithm to guide initial antibiotic therapy in acute exacerbations of COPD admitted to the ICU: a randomized multicenter study
por: Daubin, Cédric, et al.
Publicado: (2018)

Procalcitonin as a Marker of Etiology in Adults Hospitalized With Community-Acquired Pneumonia
por: Self, Wesley H., et al.
Publicado: (2017)

Value of procalcitonin, C-reactive protein, and neopterin in exacerbations of chronic obstructive pulmonary disease
por: Lacoma, Alicia, et al.
Publicado: (2011)

Serum Procalcitonin and Infective Exacerbations of Asthma
por: D'silva, Liesel, et al.
Publicado: (2011)

Usefulness of Plasma Procalcitonin to Predict Severity in Elderly Patients with Community-Acquired Pneumonia
por: Kim, Ji Hye, et al.
Publicado: (2013)

CON: Procalcitonin does not have clinical utility in children with community-acquired pneumonia
por: Banerjee, Ritu
Publicado: (2021)

Early readmission and mortality in acute exacerbation of chronic obstructive pulmonary disease with community-acquired pneumonia
por: Shin, Beomsu, et al.
Publicado: (2018)

Procalcitonin-guided antibiotic usage - addressing heterogeneity in meta-analysis
por: Birajdar, Amit Ravindra, et al.
Publicado: (2018)

Procalcitonin to Guide Antibiotic Therapy for Critically Ill Patients in Korea
por: Park, Seong Yeon
Publicado: (2019)

EARLY DISCONTINUATION OF ANTIBIOTICS BASED ON PROCALCITONIN LEVEL IN COVID-19 PNEUMONIA
por: ROY, ARCHANA, et al.
Publicado: (2021)

1336. Alcohol Impregnated Caps and Ambulatory CLABSI: Multicenter Cluster Randomized, Crossover Trial
por: Milstone, Aaron, et al.
Publicado: (2020)

Point-of-care procalcitonin test to reduce antibiotic exposure in patients hospitalized with acute exacerbation of COPD
por: Corti, Caspar, et al.
Publicado: (2016)

Impact of Procalcitonin-Guided Antibiotic Management on Antibiotic Exposure and Outcomes: Real-world Evidence
por: Broyles, Michael R
Publicado: (2017)

Procalcitonin Predicts Response to Beta-Lactam Treatment in Hospitalized Children with Community-Acquired Pneumonia
por: Cohen, Jérémie F., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_m5r1bs31q6le03ocnkhsukjtq7